SCHEMBL18593380

SCHEMBL18593380

CC(C)(C)c1cc(-n2cccc2)c(O)c(C(C)(C)C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ CA2 P00918 4/20 0.41
▸ CA1 P00915 2/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ POLB P06746 1/20 0.39
▸ TYR P14679 1/20 0.39
▸ GABRA1 P14867 1/20 0.38
▸ GABRB2 P47870 1/20 0.38
▸ GAA P10253 2/20 0.37
▸ HTT P42858 2/20 0.37
▸ XBP1 P17861 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ NR5A2 O00482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18593382 0.80 TSHR (0.44) CYP1A2CYP2C9CYP2C19CYP3A4TSHR
SCHEMBL14702255 0.77 CYP2C19 (0.42) CYP1A2CYP2C9CYP2C19CYP3A4TSHR
SCHEMBL8986512 0.76 CA2 (0.61) CYP1A2CYP2C9CYP2C19CYP3A4TSHR
SCHEMBL35141 0.76 CA2 (0.67) CYP1A2CYP2C9CYP2C19CYP3A4TSHR
SCHEMBL18612721 0.76 HSP90AA1 (0.36) CYP1A2CYP2C9CYP2C19CYP3A4TSHR
SCHEMBL26259707 0.75 ALDH1A1 (0.36) ALDH1A1POLBGABRA1GABRB2GAA
SCHEMBL9002281 0.75 TSHR (0.46) CYP1A2CYP2C9CYP2C19CYP3A4TSHR
SCHEMBL28045541 0.74 ALDH1A1 (0.44) CYP1A2CYP2C9CYP2C19CYP3A4TSHR
SCHEMBL18593377 0.74 ALDH1A1 (0.45) CYP1A2CYP2C9CYP2C19CYP3A4TSHR
SCHEMBL10491834 0.74 HSP90AA1 (0.43) CYP1A2CYP2C9CYP2C19CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9856208-B2 Method for producing an arene with an aromatic C—N bond ortho to an aromatic C—O bond THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2018-01-02 — — US disclosed
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2017-03-09 — — US disclosed
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2017-03-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170066711-A1 METHOD FOR PRODUCING AN ARENE WITH AN AROMATIC C-N BOND ORTHO TO AN AROMATIC C-O BOND AOX1, NOX4, NOXO1 CYP1A2 139/4885CYP2C9 131/4885CYP2C19 253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback